Latest filing published 15 May 2025 for 2seventy bio, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Marcela Maus V (board member) discloses dealings in 2 companies, chiefly 2seventy bio, Inc. and bluebird bio, Inc. Over a trading history stretching from 7 September 2021 to 13 May 2025, the count stands at 8 filings.
Every open-market trade on record is a sale: 1 sale worth €13k. Outside the open market, there are 5 share grants.
On 15 May 2025 came the latest disclosure, a transaction in 2seventy bio, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations